Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 1
1989 1
1990 1
1991 3
1992 3
1993 3
1994 2
1999 2
2000 2
2002 1
2003 1
2004 1
2005 1
2006 3
2007 1
2011 3
2012 2
2013 2
2014 4
2015 3
2016 3
2017 3
2018 3
2019 4
2020 3
2021 5
2022 3
2023 1
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
JID Innovations and Peer Review.
Hall RP 3rd. Hall RP 3rd. JID Innov. 2021 Oct 1;1(3):100056. doi: 10.1016/j.xjidi.2021.100056. eCollection 2021 Sep. JID Innov. 2021. PMID: 34909739 Free PMC article. No abstract available.
Picking your peers.
Goldsmith LA, Blalock EN, Bobkova H, Hall RP 3rd. Goldsmith LA, et al. Among authors: hall rp 3rd. J Invest Dermatol. 2006 Jul;126(7):1429-30. doi: 10.1038/sj.jid.5700387. J Invest Dermatol. 2006. PMID: 16778804 Free article. No abstract available.
Effective Peer Review: Who, Where, or What?
Hall RP 3rd. Hall RP 3rd. JID Innov. 2022 Oct 21;2(6):100162. doi: 10.1016/j.xjidi.2022.100162. eCollection 2022 Nov. JID Innov. 2022. PMID: 36303598 Free PMC article. No abstract available.
Dermatitis herpetiformis.
Hall RP 3rd. Hall RP 3rd. J Invest Dermatol. 1992 Dec;99(6):873-81. doi: 10.1111/1523-1747.ep12614868. J Invest Dermatol. 1992. PMID: 1469303 Free article. Review. No abstract available.
Ocular Mucous Membrane Pemphigoid: The Effect of Risk Factors at Presentation on Treatment Outcomes.
Ruiz-Lozano RE, Colorado-Zavala MF, Ramos-Dávila EM, Quiroga-Garza ME, Azar NS, Mousa HM, Hernández-Camarena JC, Stinnett SS, Daluvoy M, Kim T, Sainz-de-la-Maza M, Hall RP 3rd, Rodriguez-Garcia A, Perez VL. Ruiz-Lozano RE, et al. Among authors: hall rp 3rd. Ophthalmology. 2024 Sep;131(9):1064-1075. doi: 10.1016/j.ophtha.2024.02.028. Epub 2024 Mar 6. Ophthalmology. 2024. PMID: 38452874
Management of dermatitis herpetiformis.
Cardones AR, Hall RP 3rd. Cardones AR, et al. Among authors: hall rp 3rd. Dermatol Clin. 2011 Oct;29(4):631-5. doi: 10.1016/j.det.2011.06.015. Epub 2011 Aug 3. Dermatol Clin. 2011. PMID: 21925009 Review.
Dermatitis herpetiformis.
Otley C, Hall RP 3rd. Otley C, et al. Among authors: hall rp 3rd. Dermatol Clin. 1990 Oct;8(4):759-69. Dermatol Clin. 1990. PMID: 2249367 Review.
Evidence-based management of bullous pemphigoid.
Daniel BS, Borradori L, Hall RP 3rd, Murrell DF. Daniel BS, et al. Among authors: hall rp 3rd. Dermatol Clin. 2011 Oct;29(4):613-20. doi: 10.1016/j.det.2011.06.003. Epub 2011 Aug 6. Dermatol Clin. 2011. PMID: 21925006 Review.
66 results